Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
Recruiting · NCT06598397 · Interventional (participants receive a specific treatment) · Lead sponsor: New York University
View the official record on ClinicalTrials.gov →Interventions studied
Combination NRTMotivational Interviewing (MI) CounselingPeer MentoringSkills-based Text Messaging
What this trial is about
This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Status as HIV+
- Age 18 or older
- Currently smokes ≥ 5 CPD, on average, in past month
- Positive for salivary cotinine
- Able to understand the nature of the study and the consenting process
- Is engaged in HIV clinical care
- Living in larger NYC metropolitan area currently and for the next 6-8 months
Exclusion criteria
- Suffers from any medical condition or contraindication precluding use of nicotine replacement therapy
- Current use of any tobacco cessation medications (varenicline, NRT patch, nicotine gum, lozenge, spray or inhaler, or bupropion)
- Currently participating in a smoking cessation program
- Pregnant or nursing and plans to be in next 6 months
- Has schizophrenia/schizo-affective disorder
- Does not have a functioning mobile phone that can receive text messages
Where it is running
1 location listed across 1 US state.
- New York University School of Global Public Health - New York, New York, United States